SMARCA1 and synovial sarcoma: The underlying pathophysiology that drives the progression of synovial sarcomas is the t(X;18)(p11;q11) chromosomal translocation which affects multiple oncogenic pathways including the Wnt pathway and the SWI/SNF chromatin remodeling complex [8].